Proactive Investors - Run By Investors For Investors

Victrex on track but sees tougher comparatives ahead

Volumes rose 14% in the three months to June, while revenues increased by 10% to £84mln
Spinal implants is a competitive market

Victrex PLC’s (LON:VCT) strong first half momentum has continued said the enhanced plastics group, but the fourth quarter comparative will be tougher.

Currencies are turning and a large consumer order won’t contribute this time.

Volumes rose 14% in the three months to June, while revenues increased by 10% to £84mln and for the year to date revenues are 21% higher at £250.6mln.

Meaningful revenue

Victrex added it expects ‘meaningful revenue’ for its HA cervical and lumbar fusion device over the full year, while other oil companies are now looking at the flexible oil and plastic pipe supplied to Tullow, which deployed it in West Africa.

Currencies will become more of an issue in 2019, with an approximate £8mln-£10mln adverse effect now expected. 

Although comparatives will be tougher in Q4, and we will see currency becoming a headwind, Victrex remains comfortable with full-year expectations,” said the statement.

Shares rose 2% to 3,070p.

View full VCT profile View Profile

Victrex Timeline

Related Articles

In May, Itaconix received its first purchase order from chemical firm Nouryon for its personal care polymer following the signing of an exclusive supply agreement in February
February 18 2019
The firm specialises in using nanomaterials, including graphene, to improve or enhance the properties of products such as plastics or ceramics
Grape bunches
April 03 2019
Eden Research's first product Mevalone, a grape fungicide which is used to target the botrytis disease, is currently being sold throughout the southern EU zone and Kenya

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use